1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PE
(Synonyms: 1-Hexadecanoyl-d9-sn-glycero-3-Phosphoethanolamine, 16:0 LPE-d9, 16:0 Lyso-PE-d9, 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-Phosphoethanolamine) 目录号 : GC46491
A neuropeptide with diverse biological activities
Cas No.:2747981-09-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PE is intended for use as an internal standard for the quantification of 1-palmitoyl-2-hydroxy-sn-glycero-3-PE by GC- or LC-MS. 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE is a naturally occurring lysophospholipid.1 It inhibits the growth of L. donovani promastigotes (GI50 = 8 µM).2 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE serum levels are decreased in a mouse model of alcohol-induced liver injury and in a hepatocellular carcinoma mouse xenograft model.3 Human serum levels are also decreased immediately and 14 hours following an exercise regimen of 2.5 hours of running for three days.1 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE has been used as an internal standard for the quantification of saturated lysophosphoethanolamines.4
1.Nieman, D.C., Shanely, R.A., Gillitt, N.D., et al.Serum metabolic signatures induced by a three-day intensified exercise period persist after 14 h of recovery in runnersJ. Proteome Res.12(10)4577-4584(2013) 2.Achterberg, V., and Gercken, G.Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotesMol. Biochem. Parasitol.23(2)117-122(1987) 3.Li, S., Liu, H., Jin, Y., et al.Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in miceJ. Chromatogr. B Analyt. Technol. Biomed. Life Sci.879(24)2369-2375(2011) 4.Avadhani, M., Geyer, R., White, D.C., et al.Lysophosphatidylethanolamine is a substrate for the short-chain alcohol dehydrogenase SocA from Myxococcus xanthusJ. Bacteriol.188(24)8543-8550(2006)
| Cas No. | 2747981-09-3 | SDF | |
| 别名 | 1-Hexadecanoyl-d9-sn-glycero-3-Phosphoethanolamine, 16:0 LPE-d9, 16:0 Lyso-PE-d9, 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-Phosphoethanolamine | ||
| Canonical SMILES | O[C@@H](COP(OCCN)(O)=O)COC(CCCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O | ||
| 分子式 | C21H35D9NO7P | 分子量 | 462.6 |
| 溶解度 | Chloroform: 3 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.1617 mL | 10.8085 mL | 21.6169 mL |
| 5 mM | 0.4323 mL | 2.1617 mL | 4.3234 mL |
| 10 mM | 0.2162 mL | 1.0808 mL | 2.1617 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet